학술논문
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Document Type
Article
Author
Rescigno, Pasquale; Porta, Nuria; Finneran, Laura; Riisnaes, Ruth; Figueiredo, Ines; Carreira, Suzanne; Flohr, Penny; Miranda, Susana; Bertan, Claudia; Ferreira, Ana; Crespo, Mateus; Rodrigues, Daniel Nava; Gurel, Bora; Nobes, Jenny; Crabb, Simon; Malik, Zafar; Ralph, Christy; McGovern, Ursula; Hoskin, Peter; Jones, Robert J.; Birtle, Alison; Gale, Joanna; Sankey, Peter; Jain, Suneil; McLaren, Duncan; Chadwick, Eliot; Espinasse, Aude; Hall, Emma; de Bono, Johann
Source
In European Journal of Cancer July 2024 205
Subject
Language
ISSN
0959-8049